Life Science News

RSS

Tapping the power of cryo-ET to visualize how molecular machines interact inside cells

Scientists have often thought of cells as small bustling cities with parts that resemble factories, power grids, and shipping systems.

25 Sep 2026

Genomic study tracks massive chikungunya epidemic on Réunion Island

Between August 2024 and June 2025, Réunion Island experienced a massive chikungunya epidemic, with more than 54,000 confirmed cases and 43 deaths, making it the second major Chikungunya virus outbreak on the island after the 2005-2006 epidemic, which had affected about a third of the islands' population.

25 Sep 2026

New test identifies the genetic cause of inherited muscle disease

A world-first test developed by researchers at the Garvan Institute of Medical Research has identified the genetic cause of inherited muscle disease in people who remained without answers after years, sometimes decades, of standard testing.

25 Sep 2026

Specialized immune cells bridge the nervous and immune systems

A collaborative team led by Professor Jie Zhou at Tianjin Medical University School of Basic Medicine and Professor Qiang Liu at Tianjin Medical University General Hospital published a comprehensive review in Volume 2 of the journal Immunity & Inflammation on September 8, 2026.

25 Sep 2026

Researchers find secret protein that drives cancer cell division

A previously unknown protein, hidden in RNA thought not to encode proteins, helps cells divide correctly. The RNA molecule that encodes the protein also has a function of its own in cell division.

25 Sep 2026

Protein modification network plays vital role in cancer development

A review published in Genes & Diseases highlights the complex interplay between protein arginine methylation and ubiquitination, two forms of protein modification that can profoundly influence cancer development, progression and treatment response.

24 Sep 2026

MIT researchers build cell collection device for early cancer detection

One of the main reasons that ovarian cancer is among the deadliest forms of cancer is timing: When doctors catch it early, the five-year survival rate can be north of 90 percent.

24 Sep 2026

Review explores biological strategies of organisms with exceptional longevity

A new review was published in Volume 18 of Aging on September 8, 2026, titled "How to live for centuries: common denominators of organisms with exceptional longevity."

24 Sep 2026

Scientists uncover molecular mechanism that tunes eye light sensitivity

Weill Cornell Medicine investigators have determined the mechanism by which a molecule within cells can help tune the light sensitivity of the eyes.

24 Sep 2026

NSF awards $19 million to build 3D biological observatory for revealing life's smallest structures

How does learning change the wiring of your brain? How does a shark's eye make sense of its underwater world? How does a single-celled parasite cross the barrier that protects the brain? What might neurodegeneration look like at ultra-magnified scale?

24 Sep 2026

Gut bacteria metabolites directly extend the lifespan of host flies

Gut microbiota influences multiple aspects of host physiology, including metabolic and immune functions.

24 Sep 2026

Structural insights into synchronous calcium channel gating in muscle cells

Using cryo-electron microscopy, researchers at the Max Delbrück Center have revealed how muscle cell calcium channels open synchronously.

24 Sep 2026

Engineered nanoparticles sensitize gliomas to radiotherapy

Gliomas are a major cause of cancer-related deaths in younger adults.

24 Sep 2026

Advances in chemistry and delivery are taking oligonucleotide medicines beyond rare diseases

A review in Cell Reports Medicine examines how advances in oligonucleotide chemistry and delivery have established ASOs and RNA interference therapies as a class of genetic medicines, with 21 oligonucleotides approved at the time of writing. It also identifies extrahepatic delivery, safety, target validation, individualized treatment, and data quality as priorities as the field expands into common diseases and explores AI-assisted development.

24 Sep 2026

Forge Nano and Nanexa enter joint development agreement to advance manufacturing for ALD-coated PharmaShell® long-acting injectable medicines

Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II"), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell® drug delivery platform and its portfolio of proprietary and partnered programs.

From Forge Nano 23 Sep 2026